We operate inpatient wards at Qingchun Campus and Zhijiang Campus, with a capacity of 13 regular inpatient beds and 116 daytime treatment stations (on behalf of hospital-wide platform). Annually, we admit approximately 1,200 newly diagnosed patients and deliver treatment for around 20,000 inpatient /daycare cases.

Our department has a team of 15 physicians, including 2 doctoral supervisors and 6 master's supervisors.

Participation in the construction of the National Regional Medical Center, National Key Clinical Specialty, and Zhejiang Provincial Precision (Tumor) Healthcare Center

In recent years, the department has undertaken more than 50 clinical trials. It has led 16 projects funded by the National Natural Science Foundation of China, 2 sub-projects of National Major Science and Technology Programs, and 2 key sub-projects of the National Key R&D Program "Prevention and Treatment of Non-communicable Chronic Diseases by 2030". Additionally, it has secured 4 projects under the Zhejiang Provincial "Top Talent and Leading Innovation Team" Program and 10 projects supported by the Zhejiang Provincial Natural Science Foundation, accumulating over 10 million yuan in vertical research funding.

Over the past three years, our faculty members have published high-quality research papers as first or corresponding authors in prestigious journals including Hepatology, Molecular Therapy (3 articles), Cell Discovery, Advanced Materials, Advanced Science (2 articles), Cell Reports Medicine (2 articles), Cancer Immunology Research (3 articles), Journal for Immunotherapy of Cancer (3 articles), Oncogene, and Cancer Letters.